Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conor J Gallagher

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 9, 2018
Reduction of Submental Fat Continues Beyond 28 Days After ATX-101 Treatment: Results From a Post hoc AnalysisJeffrey S Dover, Sachin M Shridharani, Jason D Bloom, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 20, 2015
Heterogeneity of crow's feet line patterns in clinical trial subjectsMichael A C Kane, Sue Ellen Cox, Derek Jones, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 15, 2021
Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA ProgramJoel L Cohen, Lawrence J Green, Kenneth R Beer, et al.
The Australasian Journal of Dermatology|April 12, 2017
Comparison of self-reported signs of facial ageing among Caucasian women in Australia versus those in the USA, the UK and CanadaGreg J Goodman, Katherine S Armour, Julia K Kolodziejczyk, et al.
Aesthetic Surgery Journal|September 12, 2022
Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar LinesNowell Solish, Michael A C Kane, Brian S Biesman, et al.
Toxins|March 27, 2026
RTP004 Peptide Binds to Botulinum Neurotoxin, Increases Cell Surface Binding, and Enhances Cellular SNAP-25 CleavageAndre F Batista, Ratnesh Singh, Frank Lee, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 1, 2018
Relationship Between Midface Volume Deficits and the Appearance of Tear Troughs and Nasolabial FoldsDee Anna Glaser, Val Lambros, Julia Kolodziejczyk, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 28, 2024
Clinical Benefits of DaxibotulinumtoxinA for Injection: Beyond Glabellar Line Effacement?Kavita Mariwalla, Ava Shamban, Jeremy B Green, et al.
Drugs|November 17, 2021
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type ANowell Solish, Jean Carruthers, Joely Kaufman, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 26, 2016
Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled TrialsLeslie Baumann, Steven Dayan, Simon Connolly, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 9, 2018
Reduction of Submental Fat Continues Beyond 28 Days After ATX-101 Treatment: Results From a Post hoc AnalysisJeffrey S Dover, Sachin M Shridharani, Jason D Bloom, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 20, 2015
Heterogeneity of crow's feet line patterns in clinical trial subjectsMichael A C Kane, Sue Ellen Cox, Derek Jones, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 15, 2021
Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA ProgramJoel L Cohen, Lawrence J Green, Kenneth R Beer, et al.
The Australasian Journal of Dermatology|April 12, 2017
Comparison of self-reported signs of facial ageing among Caucasian women in Australia versus those in the USA, the UK and CanadaGreg J Goodman, Katherine S Armour, Julia K Kolodziejczyk, et al.
Aesthetic Surgery Journal|September 12, 2022
Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar LinesNowell Solish, Michael A C Kane, Brian S Biesman, et al.
Toxins|March 27, 2026
RTP004 Peptide Binds to Botulinum Neurotoxin, Increases Cell Surface Binding, and Enhances Cellular SNAP-25 CleavageAndre F Batista, Ratnesh Singh, Frank Lee, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 1, 2018
Relationship Between Midface Volume Deficits and the Appearance of Tear Troughs and Nasolabial FoldsDee Anna Glaser, Val Lambros, Julia Kolodziejczyk, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 28, 2024
Clinical Benefits of DaxibotulinumtoxinA for Injection: Beyond Glabellar Line Effacement?Kavita Mariwalla, Ava Shamban, Jeremy B Green, et al.
Drugs|November 17, 2021
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type ANowell Solish, Jean Carruthers, Joely Kaufman, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 26, 2016
Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled TrialsLeslie Baumann, Steven Dayan, Simon Connolly, et al.
Pageof 7